Investors Can Find Comfort In Health and Happiness (H&H) International Holdings' (HKG:1112) Earnings Quality
Soft earnings didn't appear to concern Health and Happiness (H&H) International Holdings Limited's (HKG:1112) shareholders over the last week. We think that the softer headline numbers might be getti
H&H INTL HLDG: Annual Report 2023
H&H International Holdings (01112.HK): Purchase agreement to issue US$120.20 million new notes
Gelonghui, April 8 | H&H International Holdings (01112.HK) issued an announcement. The company and the preliminary buyer entered into a purchase agreement to issue US$120.20 million 13.5% notes (“new notes”) due in 2026. After issuance, the new notes will be merged and formed into a single series with the outstanding $179.8 million 13.5% senior notes due in 2026 (“initial notes”, together with the new notes collectively referred to as “such notes”) issued on June 26, 2023. The composition date of the new note is an additional note under the contract dated June 26, 2023, excluding the date of issue and issue price
Health and Happiness (H&H) International Holdings (HKG:1112) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
H&H International Holdings (01112) grants a total of 120,000 bonus shares
Zhitong Finance App News, H&H International Holdings (01112) issued an announcement. On March 28, 2024, the board of directors decided to grant and have granted a total of 120,000 bonus shares to non-executive directors Laetitia Albertini and Ms. Mingshu Zhao Wiggins in accordance with the 2022 share award plan, but they must be accepted by each of them before it can be realized.
H&H INTL HLDG To Go Ex-Dividend On May 14th, 2024 With 0.18 HKD Dividend Per Share
March 27th - $H&H INTL HLDG(01112.HK)$ is trading ex-dividend on May 14th, 2024. Shareholders of record on May 16th, 2024 will receive 0.18 HKD dividend per share on July 10th, 2024. The ex-divide
H&H's Profit Down 5% in 2023
Health and Happiness (H&H) International Holdings (HKG:1112) recorded a 4.9% decline in attributable profit for the year ended Dec. 31, 2023, to 581.8 million yuan from 611.8 million yuan during the y
H&H International Holdings (01112) will pay the 2023 final dividend of HK$0.18 per share on July 10
H&H International Holdings (01112) announced that the company will dispatch interceptors on July 10, 2024...
H&H International Holdings (01112.HK): Adjusted EBITDA increased 12.4% to $2,215 billion in 2023
Gelonghui, March 26 | H&H International Holdings (01112.HK) announced that for the year ended December 31, 2023, the Group's revenue increased 9.0% (according to reporting basis) or 8.2% (similar comparison basis) compared to 2022 to RMB 13.926.5 billion, mainly driven by strong growth in nutritional supplements. In 2023, revenue from high-profit and rapidly growing nutritional supplements in all three strategic business divisions of the Group increased by 28.6% year-on-year on a similar comparative basis, accounting for 60.4% of the Group's total revenue. In 2023, the Group recorded gross profit of RMB 82
H&H INTL HLDG: Annual Results Announcement for the Year Ended 31 December 2023
H&H International Holdings (01112.HK): Full redemption of outstanding notes with a total principal amount of US$53.352 million
Gelonghui March 25 | H&H International Holdings (01112.HK) announced that the relevant company notified the trustees and note holders of their intention to redeem all outstanding notes on March 25, 2024. The Company has redeemed all outstanding notes (“redemptions”) with a total principal amount of $53.352 million on the redemption date at a redemption price equal to 100% of the redemption amount plus accrued and unpaid interest up to the redemption date (not including the same day). After the redemption is completed, the notes have been cancelled, and no notes have been issued. The company has applied to the Stock Exchange of Hong Kong Limited to cancel the listing of the notes. Expected revocation
Health And Happiness (H&H) International to Issue 500 Million Yuan of Bonds
Health And Happiness (H&H) International Holdings (HKG:1112) will issue bonds worth 500 million yuan, according to a Hong Kong bourse filing on Thursday. The bonds have a 7.5% coupon rate and will mat
H&H International Holdings (01112.HK) signed a subscription agreement to issue RMB 500 million bonds
Gelonghui, March 21丨H&H International Holdings (01112.HK) announced that on March 20, 2024, the company and the joint lead manager signed a subscription agreement to issue RMB 500 million of 7.5% secured bonds due in 2027. The bonds were unconditionally and irrevocably guaranteed by several of the company's existing subsidiaries. The bonds will not be listed on any stock exchange. Bonds will not be rated. According to this sale, the total proceeds from the bonds proposed for sale will be approximately RMB 500 million (before deducting underwriting discounts and other fees and expenses). Net proceeds from the company's intended use of bonds
H&H International Holdings expects an adjusted comparable net profit increase of 2% to 9% year-on-year in 2023
H&H International Holdings (01112) issued an announcement. As disclosed in the fourth quarter update announcement, it is expected that the Group's adjusted comparable net profit for the year ended December 31, 2023 will increase by the number of units compared to 2022. Based on a preliminary review of the Group's latest unaudited comprehensive management accounts for the year ended 31 December 2023, the Company hereby further informs shareholders and investors that it is expected that the Group's adjusted comparable net profit for the year ended 31 December 2023 will increase by between 2% and 9% compared to 2022, while the reported net profit is expected to be between 2% and 9%
H&H International Holdings (01112) expects a 2% to 9% year-on-year increase in adjusted comparable net profit for the year
According to the Zhitong Finance App, H&H International Holdings (01112) issued an announcement. As disclosed in the fourth quarter update announcement, it is expected that the Group's adjusted comparable net profit for the year ended December 31, 2023 will increase in units compared to 2022. Based on a preliminary review of the Group's latest unaudited comprehensive management accounts for the year ended 31 December 2023, the Company hereby further informs shareholders and investors that it is expected that the Group's adjusted comparable net profit for the year ended 31 December 2023 will increase by between 2% and 9% compared to 2022, while the reported net profit is expected to be taken
BOC International: Maintaining H&H International Holdings's “Neutral” Rating Target Price of HK$10.4
BOC International released a research report stating that it maintains the “neutral” rating of H&H International Holdings (01112), with a target price of HK$10.4. The company's stock price performance was relatively strong, mainly due to strong sales of nutritional supplements in the first nine months of 2023. However, preliminary full-year results lacked quantifiable data, so it was impossible to assess the fourth quarter's growth trend, and previous guidance meant that growth in the fourth quarter would normalize. The decline in cash balances is also the focus of investors' attention. The report said that, driven by strong growth in nutritional supplements, sales growth in 2023 was in line with expectations, but continued by infant formula
[Broker Focus] BOC International maintains H&H International Holdings (01112) neutral rating indicates that net profit falls short of expectations
Jinwu Financial News | According to BOC International Development Research Report, H&H International Holdings (01112)'s 2023 sales were in line with expectations, and net profit fell short of expectations. Also, the cash balance is lower than expected, which may attract investors' attention. The bank said sales growth in 2023 was in line with expectations, driven by strong growth in nutritional supplements, but was offset by continued weakness in infant formula. The bank continued that the main reason for the company's relatively strong stock price performance was that sales of nutritional supplements were strong in the first nine months of 2023, but the initial performance for the whole year lacked quantifiable data, so it was impossible to evaluate the growth trend in the fourth quarter
H&H International Warns of Profit Decline
Health and Happiness (H&H) International Holdings (HKG:1112) expects a single-digit year-over-year decline in net profit for 2023, the manufacturer of pediatric and adult nutrition products said in a
H&H International Holdings (01112) is expected to achieve a high number of units of revenue growth in 2023 and reports a decrease in net profit
H&H International Holdings (01112) announced that in 2023, according to reporting and similar comparison standards, this collection...
H&H International Holdings (01112.HK): Partial repurchase of 5.625% senior notes due in 2024
On February 29, Gelonghui International Holdings (01112.HK) issued an announcement regarding 5.625% senior notes (“notes”) due in 2024. From November 1, 2023 to February 28, 2024, the company has purchased additional notes with a total principal amount of US$21.99 million (equivalent to about 7.07% of the total initial principal amount of the notes) on the market. After the above repurchase, the total principal amount of the outstanding notes should be US$53.352 million (equivalent to approximately 17.78% of the total initial principal amount of the notes). The company has complied with the terms and conditions of the bill
No Data